View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/CMS RIN: 0938-AU25 Publication ID: Fall 2020 
Title: Electronic Prescribing for Controlled Substances (CMS-3394) 
Abstract:

This proposed rule would implement section 2003 of the SUPPORT for Patients and Communities Act (SUPPORT Act).  The SUPPORT Act requires that a Schedule II, III, IV, or V controlled substance covered under a Medicare Part D prescription drug plan or Medicare Advantage Prescription Drug Plan (MA/PD) be transmitted in accordance with an electronic prescription drug program beginning January 1, 2021, including when the requirement for Electronic Prescribing for Controlled Substances (EPCS) should be waived, and what (if any) penalties should be imposed on prescribers who do not use EPCS.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Other 
CFR Citation: None     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: Pub. L. 115-271, sec. 2003   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Notice With Comment  08/04/2020  85 FR 47151   
Comment Period End  10/05/2020 
NPRM  04/00/2021 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Federal 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Dan Herrmann
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Clinical Standards and Quality, MS: S3-02-01, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-7827
Email: dan.herrmann@cms.hhs.gov